Search results
Results from the WOW.Com Content Network
Over-the-counter antidiarrheal drugs may be effective for some people with lymphocytic colitis. Anti-inflammatory drugs, such as salicylates, mesalazine, and systemic corticosteroids may be prescribed for people who do not respond to other drug treatment. The long-term prognosis for this disease is good with a proportion of people suffering ...
Image of a piece of food obstructing the esophagus, a complication in lymphocytic esophagitis. Food bolus impaction is a common complication of lymphocytic esophagitis. [1] This occurs when food is acutely obstructing the esophagus at an area of narrowing and may require an endoscopic procedure in order to remove or dislodge the obstructing food.
Gluten sensitivity was reported in 23.6% and 27.3% of Crohn's disease and ulcerative colitis patients, respectively. [27] A diet high in protein, particularly animal protein, and/or high in sugar may be associated with increased risk of IBD and relapses. [28] [29]
Microscopic colitis refers to two related medical conditions which cause diarrhea: collagenous colitis and lymphocytic colitis. [ 2 ] [ 3 ] Both conditions are characterized by the presence of chronic non-bloody watery diarrhea , normal appearances on colonoscopy and characteristic histopathology findings of inflammatory cells.
Collagenous colitis is an inflammatory condition of the colon. Together with the related condition lymphocytic colitis, it is a subtype of microscopic colitis, which is characterized by inflammation that specifically affects the colon (i.e. colitis), and a clinical presentation that involves watery diarrhea but a lack of rectal bleeding.
Enterocolitis is an inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon. [1] It may be caused by various infections, with bacteria, viruses, fungi, parasites, or other causes.
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
[49] [50] When nebulized, budesonide has an bioavailability of 6% and reaches C max within 1–3 hours. [50] [49] When formulated as a rectal foam, budesonide has an bioavailability of 3% to 27% and reaches C max around 1.5 hours. [51] The plasma protein binding of budesonide is around 85-90%, with an apparent volume of distribution of 2.2-3.9L/kg.